Stephen George Dilly, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 333,186 shares at $32.59 ($10.6M) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Open-market sale of $10.6M AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,438 | $0 | 0.0% |
| 2 | $32.59 | 58,699 | $1.9M | 18.0% |
| 3 | $32.59 | 58,699 | $1.9M | 18.0% |
| 4 | $33.19 | 2,498 | $83K | 0.8% |
| 5 | $33.19 | 2,498 | $83K | 0.8% |
| 6 | $31.84 | 62,740 |
| $2.0M |
| 18.8% |
| 7 | $31.84 | 62,740 | $2.0M | 18.8% |
| 8 | $32.74 | 2,612 | $86K | 0.8% |
| 9 | $32.74 | 2,612 | $86K | 0.8% |
| 10 | $31.83 | 38,825 | $1.2M | 11.6% |
| 11 | $31.83 | 38,825 | $1.2M | 11.6% |
| Total | $31.90 avg | 333,186 | $10.6M | 100% |
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-20 | $210K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |